Quality of life assessment after 6 months of initiating treatment with tafamidis in patients with non-Val30Met mutations.

Cárdenas-Soto, Karla

Quality of life assessment after 6 months of initiating treatment with tafamidis in patients with non-Val30Met mutations. [electronic resource] - Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis - 57-58 p. digital

Publication Type: Journal Article

1744-2818

10.1080/13506129.2019.1582520 doi


Adult
Amyloid Neuropathies, Familial--drug therapy
Benzoxazoles--administration & dosage
Female
Humans
Male
Middle Aged
Mutation
Prealbumin--genetics
Quality of Life